Skip to content

Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg)

OTHER2 trials

Sponsors

University of Colorado, Denver

Conditions

Critical IllnessDisease AttributesPathologic ProcessesWounds and Injury

Related Papers